Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine PCA vs Morphine + Lidocaine PCA for vaso-occlusive crisis pain in sickle-cell anaemia
2025-523777-41-01Phase 4Authorised
- Sponsor
- Saint-Pierre University Hospital
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in sickle cell anemia (SCA) comparing Morphine PCA with Morphine + Lidocaine PCA (2 arms). Primary endpoint: Morphine consumption. Planned start Jan 2026; status: authorised.
02
Drugs
morphinelidocaine
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on 2025-523777-41-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523777-41-01.